These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30600674)

  • 21. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent pyogenic cholangitis with hepatolithiasis--the role of surgical therapy in North America.
    Al-Sukhni W; Gallinger S; Pratzer A; Wei A; Ho CS; Kortan P; Taylor BR; Grant DR; McGilvray I; Cattral MS; Langer B; Greig PD
    J Gastrointest Surg; 2008 Mar; 12(3):496-503. PubMed ID: 17999121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong.
    Co M; Pang SY; Wong KY; Ip WK; Yuen WK
    HPB (Oxford); 2014 Aug; 16(8):776-80. PubMed ID: 24246050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.
    Kim HJ; Kim JS; Suh SJ; Lee BJ; Park JJ; Lee HS; Kim CD; Bak YT
    World J Surg; 2015 Jun; 39(6):1537-42. PubMed ID: 25648078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopy versus open left lateral segmentectomy for recurrent pyogenic cholangitis.
    Tang CN; Tai CK; Ha JP; Siu WT; Tsui KK; Li MK
    Surg Endosc; 2005 Sep; 19(9):1232-6. PubMed ID: 16132325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Transplant for Cholangiocarcinoma.
    Zamora-Valdes D; Heimbach JK
    Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
    Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
    Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
    Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
    Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of Populations at Risk of Cholangiocarcinoma Development in Rural Communities of Thailand Using the Korat-CCA Verbal Screening Test.
    Kaewpitoon SJ; Rujirakul R; Loyd RA; Panpimanmas S; Matrakool L; Tongtawee T; Kompor P; Norkaew J; Chavengkun W; Wakkhuwattapong P; Kujapun J; Ponphimai S; Phatisena T; Eaksunti T; Polsripradist P; Joosiri A; Sukkasam I; Padchasuwan N; Kaewpitoon N
    Asian Pac J Cancer Prev; 2016; 17(4):2205-9. PubMed ID: 27221919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic retrograde cholangiopancreatography and endoscopic papillotomy in recurrent pyogenic cholangitis.
    Choi TK; Wong J
    Clin Gastroenterol; 1986 Apr; 15(2):393-415. PubMed ID: 3731519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.
    Al Mamari S; Djordjevic J; Halliday JS; Chapman RW
    J Hepatol; 2013 Feb; 58(2):329-34. PubMed ID: 23085647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.